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Abstract  
Central administration of neurokinin B (NKB) agonists stimulates immediate early gene expression in 
the hypothalamus and increases secretion of vasopressin from the posterior pituitary through a 
mechanism that depends on the activation of neurokinin receptor 3 receptors (NK3R). Here we report 
that, in the rat, immunoreactivity for NK3R is expressed in magnocellular vasopressin and oxytocin 
neurones in the supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus, 
and that NKB immunoreactivity is expressed in fibres in close juxtaposition with vasopressin 
neurones at both of these sites. Retrograde tracing in the rat showed that some NKB-expressing 
neurones in the arcuate nucleus project to the SON, and in mice, using an anterograde tracing 
approach, we found that kisspeptin-expressing neurones of the arcuate nucleus, which are known to 
co-express NKB, project to the SON and PVN. Finally, we show that i.c.v. injection of the NK3R 
agonist senktide potently increases the electrical activity of vasopressin neurones in the SON in vivo 
with no significant effect detected on oxytocin neurons. The results suggest that NKB-containing 
neurones in the arcuate nucleus regulate the secretion of vasopressin from magnocellular neurones in 
rodents, and we discuss the possible significance of this.  
 
Introduction 
The peptide hormone vasopressin is synthesised in magnocellular neurosecretory neurones in 
the supraoptic (SON) and paraventricular (PVN) nuclei of the hypothalamus, and is the main 
hormonal regulator of plasma osmolality and body water content. In the elderly, about half of all cases 
of chronic hyponatremia are attributed to chronically elevated secretion of vasopressin (1). In humans, 
vasopressin secretion progressively increases with age (2, 3), and the size of magnocellular 
vasopressin neurons in the SON and PVN is increased after the age of 60 years, suggesting that there 
is also an increase in vasopressin production (2, 4). In aged rodents, there is also an increase in 
vasopressin secretion, and this has been linked to impaired osmoregulation (5). Aging is also 
associated with a marked decline in sex steroid production in both men and women, but whether the 
age-related increase in vasopressin synthesis and secretion is linked to age-related decline in sex 
steroid production is not known.  
In this study, we explored neuroanatomical and functional interactions between neurons that 
express neurokinin B (NKB) and magnocellular vasopressin neurons. NKB, a member of the 
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biological effects of tachykinins are mediated by three different neurokinin receptors: NK1R, NK2R, 
NK3R, and NKB preferentially binds to NK3R (6). The earliest evidence of a role for NKB in human 
reproduction came from a study of postmenopausal women by Rance and Young (7) which 
demonstrated hypertrophy and hyperplasia of cells containing NKB in the infundibular nucleus – the 
nucleus homologous to the arcuate nucleus in rodents. Similar results have since been found in the 
infundibular nucleus of the aging man (8). This led to the recognition that NKB expression is 
inversely correlated to levels of circulating sex steroids. Thus, for example, NKB expression is greatly 
elevated by gonadectomy in a manner reversible by replacement with sex steroids (9). A similar 
pattern has been described in monkeys, where ovariectomy results in neuronal hypertrophy and an 
increase of NKB mRNA expression (10). In addition, gonadal steroids have been reported to have 
marked effects on the somata and dendrites of arcuate nucleus NKB neurons (11).  
There is already considerable evidence that the NKB/NK3R system may regulate vasopressin 
secretion. Central injection of a selective NK3R agonist, senktide, induces antidiuresis by increasing 
peripheral vasopressin secretion (12), whereas neurokinin A, substance P and selective NK-1 agonists 
have no such effect. The actions of senktide are likely to be direct, as mRNA for NK3R is expressed 
in both the SON and PVN (13), and as senktide can also stimulate vasopressin secretion from explants 
of the hypothalamo-hypophysial system (14). Conversely, central administration of a NK3R 
antagonist reduces osmotically-stimulated vasopressin secretion in rats (15).  
In this study, using immunocytological and electrophysiological approaches, we aimed to 
determine 1) whether there is an anatomical connection between the NKB-producing neurones in the 
arcuate nucleus and vasopressin neurones in the SON and PVN, and 2) the effects of the NK3R 
agonist, senktide, on the electrical activity of magnocellular vasopressin and oxytocin neurones in the 
SON.  
Materials and Methods 
Experiments were performed on adult male Sprague–Dawley rats (body weight ~ 300 g) and 
adult male transgenic Kiss1/Cre-eGFP mice (body weight ~ 30 g) that had been housed on a 12:12 h 
light:dark cycle (lights off at 19.00 h) with free access to food and water. All experiments were 
conducted in accordance with a UK Home Office project licence that has been reviewed by the 
University of Edinburgh Ethics Committee. 
Tracing/Connectivity studies 
For retrograde tracing experiments, we used retro-beads as they show very limited spread 
from the injection site, and do not need an antibody for detection (16). The injection method we used 
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maintained on 1.5 – 2% isoflurane. They were placed in a stereotaxic frame and a glass capillary was 
implanted in SON using the following coordinates (18): anterioposterior -1.3 mm; mediolateral 2.0 
mm; dorsoventral 9.4 mm. Red retro-beads (Lumafluor, Inc.) were injected in the SON (100 nl) by 
pressure injection. Once the wound was sutured, rats were given buprenorphine (0.03 mg/kg) 
subcutaneously. One week after injection, the rats were transcardially perfused, and the brains were 
removed and processed for immunofluorescence as described below. 
Anterograde tracing 
Recombinant adeno-associated virus vectors (rAAVs) have been commonly used to deliver 
genes of interest into the central nervous system in vivo. Here we used a cre-dependent approach to 
deliver YFP specifically to arcuate nucleus kisspeptin neurons (19, 20). Kisspeptin-expressing 
neurons in the arcuate nucleus of rodents (21, 22), sheep (23), and monkey (24) co-express NKB and 
dynorphin. Using this property of arcuate kisspeptin neurons, we used the transgenic Kiss1/Cre-eGFP 
knock-in mouse (25) to trace kisspeptin arcuate nucleus projections to the SON and PVN.  
We used an AAV where an inverted YFP reporter sequence was floxed by two LoxP 
sequences oppositely oriented. Thus, after the cre-recombinant event in kisspeptin cells, YFP was 
orientated to the correct sense and transduced specifically in cre cells only under the constitutively-
expressed elongation factor 1-alpha promoter (Ef1a) (26, 27). This type of AAV, commonly known as 
a DIO-AAV, was purchased from Gene Therapy Center Vector Core (University of North Carolina; 
serotype 5; viral titer 1012 vg/ml). Using a similar approach to that described in the retrograde tracing 
study above, Kiss1/Cre-eGFP mice were injected with 300 nl of the DIO-AAV into the arcuate 
nucleus following the coordinates (28): anterioposterior -1.8 mm; mediolateral 0.3 mm; dorsoventral 
5.8 mm. Although this transgenic line expresses eGFP under the kisspeptin promoter, this expression 
is restricted to the nucleus, thus, any YFP projections found come from the AAV-DIO-YFP. Three 
weeks after injection, mice were perfused transcardially with paraformaldehyde, and the brains were 
removed and processed for double immunofluorescence as described below. 
Immunofluorescence protocols 
Adult male rats (body weight ~300 g) and adult male Kiss1/Cre-eGFP mice were injected 
with a lethal dose of sodium pentobarbitone and transcardially perfused with heparinised 0.9% saline, 
followed by 4% paraformaldehyde in 0.1 M phosphate-buffered saline (pH 7.3-7.4). Brains were 
extracted and post-fixed overnight at 4ºC in 2% PFA + 15% sucrose solution then cryoprotected in 
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For NK3R and NKB immunoreactivity studies, sections were mounted on SuperFrost Plus 
slides then dried for 1 h at 37ºC. Sections were washed in PBS-T (0.1% Tween-20) for 10 min at 
room temperature. Heat-induced epitope retrieval (HIER) was then performed in 10 mM sodium 
citrate pH 6 for 10 min at 90ºC. Afterwards, sections were cooled to room temperature and then 
washed for 5 min in PBS at room temperature. The sections were incubated in blocking buffer (3% 
donkey or goat serum, 0.4% Triton X-100 in PBS) for 45 min at room temperature. Next, the sections 
were incubated with primary antibodies (Table 1) in blocking buffer for two days at 4ºC, then washed 
three times for 10 min in PBS. Finally, the sections were incubated with secondary antibodies (Table 
1) in blocking buffer for 1 h at 37ºC, then washed three times for 10 min in PBS, and mounted on 
slides using PermaFluor Aqueous Mounting Medium (Thermo Scientific, TA-030-FM). No signal 
was detected after applying secondary antibodies in the absence of primary antibodies. 
For the anterograde tracing study using AAV, we used the same protocol as described above 
but without the HIER step. The anterograde tracing study did not allow us to use simultaneously 
visualize NKB by immunohistochemistry. While the specificity of the NKB antibody is high, its 
sensitivity is low, and we were able to label fibres only after the HIER step, which compromises the 
detection of YFP.  
For the retrograde tracing study, we used free-floating sections. Sections were washed twice 
for 10 min in 0.1 M PB, then incubated for 30 min in freshly made 1% (w/v) sodium borohydride in 
0.1 M PB, and washed four times for 10 min in 0.1 M PB They were then incubated 30 min in 0.1 M 
Glycine and washed four times for 10 min in 0.1 M PB followed by 45 min in blocking solution of 
3% donkey serum + 0.4% triton X-100 in 0.1 M PB. Next, free-floating sections were incubated with 
primary rabbit NKB antibody (Table 1) diluted in blocking buffer for 2 days at 4ºC. After incubation 
with the primary antibody, sections were washed four times for 10 min in 0.1 M PB, followed by a 2 h 
incubation with secondary anti-rabbit antibody Alexa 488 (Table 1). Finally, sections were mounted 
in SuperFrost Plus slides using Fluoromount (Sigma -F4680) after washing. All incubations were at 
room temperature unless stated.  
Immunoreactivity was visualized on the Nikon A1R FLIM confocal system. Images were 
viewed and Z stacks condensed to maximum intensity projections using NIS-Elements Viewer 
software. Resulting images were exported to the ImageJ software. To facilitate color-blind readers, 
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Table 1: Primary and secondary antibodies used in the immunofluorescence assays. 
Primary Abs Code Supplier Dilution Raised in: 
Vasopressin- 
neurophysin 
PS41 Dr H Gainer 1/500 mouse 
Oxytocin- 
neurophysin 
PS38 Dr H Gainer 1/500 mouse 
NK3R IS-7/7 Dr Philippe Ciofi 1/3,000 rabbit 
NKB NB300-201 Novus Biologicals 1/800 rabbit 
GFP/YFP Ab13970 Abcam 1/10,000 chicken 
Secondary Abs Code Supplier Dilution Raised in: 
Alexa Fluor® 488 
Anti-Rabbit 
A-21206 Life Technologies  1/500 donkey 
Alexa Fluor® 555 
Anti-Mouse  
A-31570 Life Technologies  1/500 donkey 
Alexa Fluor® 488 
Anti-Chicken  
A-11039 Life Technologies  1/500 goat 
Alexa Fluor® 555 
Anti-Mouse  
A-21422 Life Technologies  1/500 goat 
 
In vivo electrophysiology 
Adult male rats were anesthetized with urethane (1.25 g/kg, i.p.), a femoral vein was 
cannulated and a catheter was inserted in the trachea. The SON and an area rostral to the pituitary and 
on the midline were exposed transpharyngeally, as described fully elsewhere (29). A microinjection 
cannula was placed 0.5-1 mm rostral to the neural stalk and on the midline then lowered into the third 
ventricle to inject 600 pmol of senktide in a volume of 2 µl over 100 s. Under visual control, a glass 
microelectrode (tip diameter ~ 1 µm) filled with 0.9% NaCl was placed in the SON to record from 
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In this study, unlike our previous electrophysiological studies on SON neurones, we could not 
identify these neurones antidromically as projecting to the posterior pituitary gland because inserting a 
microinjection cannula ventrally into the 3rd ventricle did not leave enough space to also place a 
stimulating electrode on the neural stalk and a recording electrode in the SON. We therefore used 
other ways to ensure that we recorded from magnocellular neurones: 1) the ventral approach allows us 
to visually place the recording electrode on the surface of the brain just below the SON (which, unlike 
the PVN, contains only magnocellular neurons); 2) phasically firing cells in this area can only be 
magnocellular vasopressin neurones; 3) we checked the shape of interspike-interval histograms and 
hazard functions of the recorded cells, as these reveal the characteristic firing patterns of SON 
vasopressin and oxytocin neurones as shown previously (30). Oxytocin cells were distinguished from 
vasopressin cells by their firing pattern and by their opposite response to intravenous CCK [20 μg/kg; 
cholecystokinin-(26-33)-sulfated; Bachem, Essex, UK]. In phasic neurones, burst patterning (activity 
quotient and intraburst firing rate) was analysed as described elsewhere (30). 
Responses to senktide were analysed by comparing the mean firing rate in 10-min intervals 
after senktide injection with the (basal) firing rate measured in a 10-20 min control period before 
senktide injection. Only one injection of senktide was made in each experiment, so the results shown 
are those from individual rats. Responses to senktide were very prolonged, and we quantified effects 
by comparing activity in the period between 20 and 40 min after injection with the activity in the 10 
min before injection, and tested the significance of differences using a 2-tailed Mann-Whitney test. 
For phasic firing neurones, bursts were recognized by a conventional algorithm (30) according to the 
criteria: minimum length 3 s; minimum interburst period 3 s; maximum intraburst interspike interval 1 
s; minimum 20 spikes per burst; maximum interval at start of burst 0.8 s. Having identified bursts and 
silences, we calculated the activity quotient (AQ = time active / time recorded) and the intraburst 
spike frequency. For all neurones, we constructed interspike interval histograms (in 5-ms bins) for the 
periods analysed, and then constructed hazard functions according to the formula (hazard in bin [t, t+ 
5]) = (number of intervals in bin [t, t+ 5])/(number of intervals of length > t). 
 
Results 
NK3R and NKB immunoreactivity in the SON and PVN. 
In the SON and PVN (Fig 1,2), we found dense expression of NK3R immunoreactivity 
whereas the surrounding perinuclear zones were apparently devoid of NK3R immunoreactivity, 
indicating a strong and specific expression of NK3R in magnocellular neurones. Within the SON and 
PVN, the immunoreactivity was mainly absent from cell nuclei, and apparently mainly (but not 
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was co-localized with both vasopressin-neurophysin (Fig. 1) and oxytocin-neurophysin (Fig. 2). 
NK3R expression was also found in all the accessory magnocellular nuclei including in the nucleus 
circularis, and in the retrochiasmatic part of the SON (images not shown). In the SON, NK3R was 
expressed in all neurones, but in the PVN it was preferentially expressed in vasopressin cells (Fig 1C, 
Fig. 2C). To quantify this, we analysed sections of the PVN from three rats, sampling cells that 
expressed vasopressin-neurophysin or oxytocin-neurophysin, and which could be unambiguously 
defined as NK3R-positive or NK3R-negative. Of 111 vasopressin cells, 99 co-expressed NK3R 
(89%), whereas of 128 oxytocin cells, only 36 (28%) co-expressed NK3R.   
Consistent with previous studies, we observed a large population of NKB-expressing cells in 
the caudal arcuate nucleus (not shown). NKB-positive fibers from these cells passed through the 
rostral arcuate nucleus, and some of these could be seen to enter the caudal region of the SON (Fig. 
3A); other fibres coursed dorsally towards the PVN alongside the walls of the third ventricle (Fig 3A). 
Within both the SON and PVN, we found abundant expression of NKB-expressing fibres with 
boutons in close juxtaposition to vasopressin cells (Fig. 3B,C). However, we did not find any NKB-
expressing cell bodies in either of these nuclei. 
 
Projections of NKB-expressing cells from the arcuate nucleus 
Retrograde study These immunohistochemical studies suggested that at least some of the NKB 
projections found within the SON originated from NKB-expressing cells in the caudal arcuate 
nucleus. To test this, we aimed to inject retro-beads into one SON side in six rats, and present here the 
results from two rats in which the injection was on target with minimal spread outside the SON (Fig. 
4A). We used a small volume of retro-beads to achieve higher specificity, so we expected to inject 
only a small area of the SON and therefore only a few fibres were likely to uptake the beads. A week 
after injection, retro-beads injected into the SON were found in the cytoplasm of 11% of NKB-
expressing cells (27 out of 238 cells) in the caudal arcuate nucleus (Fig. 4B-F). 
Anterograde study We injected a cre-dependent AAV-DIO-YFP in the arcuate nucleus of three kiss1-
Cre/eGFP mice, and present here the results from two mice in which the injection was on target (Fig. 
5A). We found YFP-expressing fibers in the PVN and SON (Fig. 5B,C), indicating that some 
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Effect of NKB on the electrical activity of SON vasopressin and oxytocin neurones 
In the SON of urethane-anaesthetised rats we recorded from 17 vasopressin neurones (mean 
basal rate 5.1 ± 0.76 spikes/s), of which 10 were firing phasically and seven were firing continuously. 
Those firing continuously were identified as vasopressin neurones by their response to CCK 
(inhibition or no response) and by analysing the nature of their firing pattern: hazard functions 
constructed from interspike interval data revealed the presence of a post-spike hyperexcitability that is 
uniformly present in vasopressin neurones (30) but mainly absent from oxytocin neurones (Fig. 6B). 
Of the 17 neurones, one phasic neurone was lost at 10 min after senktide injection, after 
increasing its firing rate from 8.0 to 9.7 spikes/s in that time. The other 16 neurones were all kept for 
between 30 and 60 min after injection, and the mean firing rate of these, averaged over 20-40 min 
after injection, was 2.1 ± 0.7 spikes/s higher than the basal rate (Fig. 6A and C; P = 0.008, Mann-
Whitney test).  
The nine phasically firing neurones that were held for more than 30 min had a mean basal rate 
3.3 ± 0.7 spikes/s (range 0.5 - 8 spikes/s); this activity comprised bursts and intervening silences, and 
to assess whether the response to senktide was due to a change in the burst length or/and a change in 
burst intensity we analysed the changes in the activity quotient (AQ = time active / time recorded) and 
in the intraburst frequency. The AQ was raised by 0.19 ± 0.11 from 0.49 ± 0.07 to 0.68 ± 0.1 at 20-40 
min after senktide injection (Fig. 6E), and intraburst frequency was increased by 1.1 ± 0.6 spikes/s 
from 6.2 ± 0.5 spikes/s to 7.3 ± 0.7 spikes/s (Fig. 6F). 
The seven continuously firing vasopressin neurones had a mean basal firing rate of 7.5 ± 1.7 
spikes/s (range 1.9 - 10.7 spikes/s). Between 20 and 40 min after senktide injection, the mean firing 
rate was 1.7 ± 0.7 spikes/s higher than basal; in one of these neurones the firing rate was lower (by 0.9 
spikes/s), but in five of the neurones it was increased by at least 1.5 spikes/s. 
We also recorded from seven putative oxytocin neurones (mean basal rate 5.25 ± 0.8 spikes/s; 
range 2.6 - 6.9 spikes/s), all of which were recorded in close proximity to identified vasopressin 
neurones, and which were identified either by their excitatory response to i.v. CCK or by the shape of 
their interspike-interval histograms and resulting hazard functions (30). Overall, senktide had no 
significant effect on the electrical activity of these neurones (mean change at 20-40 min after senktide, 
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Discussion 
Here, we confirmed that, in the rat, as previously reported (31), neurokinin receptor NK3R is 
densely expressed in vasopressin and oxytocin cells in the SON and PVN. We also confirmed that, in 
the PVN, NK3R is expressed by most vasopressin cells but by only some oxytocin cells (32); but in 
the SON it appeared that all neurones, including all oxytocin cells, express NK3R. NKB was 
expressed in fibres in close juxtaposition with vasopressin cells in both the SON and PVN. However, 
we failed to find NKB expression in cell bodies in either the SON or the PVN, in accord with in situ 
hybridisation studies which failed to detect NKB mRNA expression in these nuclei (33-35), but in 
contradiction to a previous study which reported co-immunostaining of NKB and vasopressin in SON 
and PVN neurones (36). We also showed that some NKB-expressing cells in the rat arcuate nucleus 
project to the SON, and in mice, we found by anterograde tracing that arcuate kisspeptin-expressing 
cells, which are known to co-express NKB, project to both the SON and PVN.  
Finally, we showed that i.c.v. injection of the NK3R agonist senktide increases the electrical 
activity of vasopressin neurones but not oxytocin neurones in the SON. This is consistent with 
previous studies showing an increase in vasopressin secretion after i.c.v. administration of selective 
NK3R agonists (37), and an increase in Fos expression in the SON and PVN after i.c.v. administration 
of senktide (10, 38). Here we used a dose of senktide (∼ 0.5 μg) that has been reported to be maximal 
for inducing Fos expression in the SON and PVN (38).  
It has previously been reported that i.c.v injections of senktide stimulate oxytocin secretion 
into the plasma, but this appears to be an indirect effect as it could be blocked by the adrenergic 
antagonist phentolamine (39). The significance of NK3R expression in magnocellular oxytocin 
neurones thus remains uncertain; it appears not to be able to activate dendritic oxytocin release as, in 
the same study, no release of oxytocin within the PVN was found by microdialysis in response to 
senktide. In vasopressin cells, NK3R receptors are internalised after ligand binding and subsequently 
translocated to the nucleus (40). Interestingly, both hyperosmotic stimulation (40, 41) and 
hypotension (40) as well as senktide result in translocation of NK3R from the cytoplasm to the 
nucleus of vasopressin cells in the SON and/or PVN. This raises the possibility that in diverse 
physiological circumstances NK3R has a role in transcriptional regulation in vasopressin cells (42), 
and perhaps also in oxytocin cells.  
Connections between the arcuate nucleus and the SON have been shown anatomically and 
electrophysiologically in previous studies; in particular, the SON is innervated by β-endorphin- and 
ACTH-containing fibres originating from the arcuate nucleus (43, 44). Electrical stimulation of the 
arcuate nucleus results in a complex response in SON neurones characterised by a fast inhibitory 
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excitatory component is not known, but the present data suggest that NKB may contribute to this 
component of the activation in vasopressin neurones.  
In neurones of the arcuate nucleus, NKB is co-localised with kisspeptin and dynorphin, so 
projections of this pathway to oxytocin and vasopressin neurones may have different actions 
depending on which receptors are present postsynaptically, and possibly also depending on 
differential targeting of peptides to secretory vesicles at different sites. Dynorphin is likely to be 
inhibitory to both oxytocin and vasopressin neurones in the SON via its actions at kappa-opioid 
receptors that are expressed on both of these neuronal types (47), but the effects of kisspeptin are less 
clear. Intravenous kisspeptin has excitatory effects on most oxytocin neurones in the SON but on only 
a minority of vasopressin neurones (48), but that same study reported no significant effect of i.c.v. 
kisspeptin on either oxytocin or vasopressin neurones in the SON, suggesting that the effects of 
intravenous kisspeptin were mediated indirectly, possibly via the vagus. However a subsequent study 
by the same authors suggested that an excitatory action of i.c.v. kisspeptin on oxytocin neurones of 
the SON is apparent in late pregnancy and lactation (49). The physiological significance of this is not 
clear: it may be, as the authors suggested, that kisspeptin has a specific role in lactation, perhaps in 
supporting bursting activity in response to suckling and during parturition. However, as lactation is 
apparently associated with a downregulation of kisspeptin and NKB expression in the arcuate nucleus 
(50), it may also be that the heightened responsiveness of oxytocin neurones to kisspeptin in lactation 
reflects upregulation of NK3R expression in response to ligand withdrawal. 
Thus the physiological role of the NKB projection to the SON is, at present, unclear, but 
because this projection is conspicuously modulated by gonadal steroids, it seems possible that it 
mediates the influence of gonadal steroids on the expression and secretion of vasopressin and/or 
oxytocin. Neither the magnocellular oxytocin neurones nor the magnocellular vasopressin neurones 
express the classical oestrogen receptor, yet the synthesis of oxytocin and the secretion of both 
oxytocin and vasopressin are modulated by oestrogen (51-53). 
 
  Vasopressin regulates water uptake in the distal renal tubules and elevated levels can result 
in hyponatremia. In the elderly, hyponatremia, the most common electrolyte disorder, can be a serious 
health burden: common complications include an increased incidence of falls resulting from mental 
confusion, and osteoporosis, together giving an increased risk of fractures. About half of all cases of 
chronic hyponatremia are attributed to chronically elevated secretion of vasopressin (1, 2): in humans, 
vasopressin secretion progressively increases with age (3, 5), and the size of magnocellular 
vasopressin neurones in the SON and PVN is increased after the age of 60 years, suggesting that there 
is also an increase in vasopressin production (2). In aged rodents, there is also an increase in 
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Aging is also associated with a marked decline in sex steroid production in both men and 
women. This decline leads to an increase in the expression of NKB in the hypothalamus of humans 
and rodents alike, and may contribute to the progressive rise in vasopressin secretion that 
accompanies aging (2). In aging, chronic hyponatremia resulting from inappropriately increased 
vasopressin secretion has been causally linked to osteoporosis, as has reduced gonadal steroid 
secretion. Osteoporosis has an incidence peak in advanced age, particularly in postmenopausal 
women (55), it has been associated with hyponatremia (56), and almost 50% of reports of chronic 
hyponatremia are due to inappropriately elevated secretion of vasopressin (1, 57). Thus, recognizing 
the causal chain by which aging results in inappropriately increased vasopressin secretion may lead to 
new targets for preventing osteoporosis.  
 
Figure legends 
Figure 1. Expression of NK3R (green) in vasopressin cells (magenta) in coronal sections of the rat 
SON (A,B) and PVN (C,D). B and D are enlarged views of the highlighted square areas indicated in 
the right panels of A and C. The white arrows indicate examples of cells in which NK3R and 
vasopressin-neurophysin (VP-NP) immunoreactivity co-localize. Note the expression of NK3R in 
fibres and cell membranes highlighted in the cell arrowed in D.  3V, third ventricle; OC, optic chiasm. 
 
Figure 2. Expression of NK3R (green) in oxytocin cells (magenta) in coronal sections of the rat SON 
(A) and PVN C). B and D are enlarged views of the highlighted square areas indicated in the right 
panels of A and C. The white arrows indicate examples of cells in which NK3R and oxytocin-
neurophysin (OT-NP) immunoreactivity co-localize. Note the expression of NK3R in axons and cell 
membranes highlighted in the cells arrowed in D.  OC, optic chiasm; 3V, third ventricle. 
 
Figure 3. (A) NKB (green) and vasopressin-neurophysin (VP-NP; magenta) immunoreactivity in a 
coronal section of the rat anterior hypothalamus. Note that NKB fibres project from the rostral arcuate 
nucleus laterally towards the SON, and dorsally towards the PVN. NKB-expressing fibres (green) are 
apparent in coronal sections of the SON (B) and PVN (C). These fibres were found in close 
juxtaposition to vasopressin cells in both the SON (B) and PVN (C). The panels to the right show 
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Figure 4. (A) Coronal section of the rat SON showing the injection site of retro-beads (magenta). (B) 
Coronal section showing an example of localization of NKB (green) and retro-beads (magenta) in the 
arcuate nucleus following injection of retro-beads in the rat SON. (C) Enlarged view of (B) showing a 
cell (white arrow) that contains a large number of beads but no NKB and a cell that expresses NKB 
and contains a few beads (yellow arrow) D shows the cell in C taken at a different focal plane 
showing these beads clearly within the cell. E shows another example of a an NKB-expressing cell 
containing beads, and F gives a  3D reconstruction of the cell shown in (E), illustrating how we 
confirmed the presence of beads within cells. TD, transmitted light channel; OC, optic chiasm. 
 
Figure 5. A coronal section of the arcuate nucleus in a kiss1-Cre/eGFP mouse showing kisspeptin 
cells labeled with YFP (yellow). Background staining with nuclear marker Hoechst (blue). B shows 
kisspeptin projections (yellow) and vasopressin-neurophysin (VP-NP; magenta) immunoreactivity in 
coronal sections of the kiss1-Cre/eGFP mice in the SON (B) and PVN (C). The panels on the right are 
enlargements of the white squares indicated in the panels to the left, and show YFP-containing fibres 
in close juxtaposition to vasopressin cells. 3V, third ventricle; OC, optic chiasm. 
 
Figure 6. Changes in electrical activity in magnocellular vasopressin and oxytocin neurones of the 
SON in response to i.c.v. injection of senktide (600 pmol in 2µl) in vivo. (A) Representative recording 
showing the increase in electrical activity in a phasically firing vasopressin neurone in response to 
senktide: the firing rate is plotted in 1-s bins. (B) Mean (SE) hazard functions for vasopressin (white 
circles) and oxytocin neurones (black diamonds). (C) Mean (SE) change in firing rate per 10-min bins 
in vasopressin (white circles) and oxytocin neurones (black diamonds); (D) Extract of voltage 
recording showing individual spikes; the extract is from the portion of the recording indicated by the 
dotted lines. (E) Mean change in activity quotient in phasic vasopressin neurones; (F) Mean change in 
intraburst frequency in phasic vasopressin neurones.  
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